Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Taro Pharmaceutical Industries Ltd (TARO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Taro Pharma Industries's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
42.40 -0.08    -0.19%
26/04 - Closed. Currency in USD ( Disclaimer )
After Hours
42.40
-0.00
-0.00%
19:00:00 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 27,051
  • Bid/Ask: 42.18 / 42.66
  • Day's Range: 42.23 - 42.49
Taro Pharma Industries 42.40 -0.08 -0.19%

Taro Pharmaceutical Industries Ltd Company Profile

 
Get an in-depth profile of Taro Pharmaceutical Industries Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

1554

Equity Type

ORD

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug chains, food chains, hospitals, mass merchandisers, e-commerce stores, and other direct consumers, as well as healthcare institutions and private pharmacies. The company was incorporated in 1959 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Alkaloida Chemical Company Zrt. As of June 30, 2023, Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Sun Pharmaceutical Industries Limited.

Contact Information

Address 14 Hakitor Street Haifa Bay
Haifa, 2624761
Israel
Phone 972 4 847 5700
Fax -

Top Executives

Name Age Since Title
Dilip Shantilal Shanghvi 66 2013 Chairman of the Board
Uday V. Baldota 51 2016 CEO & Director
Linda Benshoshan 55 2016 Independent Director
Abhay Gandhi 56 2016 Vice Chairman
James Kedrowski 70 2010 Director
Sudhir Vrundavandas Valia 65 2010 Director
Robert Benjamin Stein 72 2020 Independent Director
Oded Sarig - 2023 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TARO Comments

Write your thoughts about Taro Pharmaceutical Industries Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jignasha Panchal
Jignasha Panchal Aug 08, 2019 12:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
• Taro Pharmaceutical (NYSE:TARO): Q1 EPS of $1.71 misses by $0.62.• Revenue of $154.62M (-4.2% Y/Y) misses by $24.92M.
Jignasha Panchal
Jignasha Panchal Aug 08, 2019 12:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
• Taro Pharmaceutical (NYSE:TARO): Q1 EPS of $1.71 misses by $0.62.• Revenue of $154.62M (-4.2% Y/Y) misses by $24.92M.
Binoy Roy
Binoy Roy May 14, 2019 2:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It will go below 95.
Gaurav Up
Gaurav Up Dec 04, 2018 10:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it will move above 110
Gaurav Up
Gaurav Up Dec 04, 2018 10:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it will move above 110
Gaurav Up
Gaurav Up Dec 04, 2018 10:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it will move above 110
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email